These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 28205547)

  • 21. Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline.
    Ben-Dov IZ; Tan YC; Morozov P; Wilson PD; Rennert H; Blumenfeld JD; Tuschl T
    PLoS One; 2014; 9(1):e86856. PubMed ID: 24489795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
    Chen L; Zhou X; Fan LX; Yao Y; Swenson-Fields KI; Gadjeva M; Wallace DP; Peters DJ; Yu A; Grantham JJ; Li X
    J Clin Invest; 2015 Jun; 125(6):2399-412. PubMed ID: 25961459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA501-5p induces p53 proteasome degradation through the activation of the mTOR/MDM2 pathway in ADPKD cells.
    de Stephanis L; Mangolini A; Servello M; Harris PC; Dell'Atti L; Pinton P; Aguiari G
    J Cell Physiol; 2018 Sep; 233(9):6911-6924. PubMed ID: 29323708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mcp1 Promotes Macrophage-Dependent Cyst Expansion in Autosomal Dominant Polycystic Kidney Disease.
    Cassini MF; Kakade VR; Kurtz E; Sulkowski P; Glazer P; Torres R; Somlo S; Cantley LG
    J Am Soc Nephrol; 2018 Oct; 29(10):2471-2481. PubMed ID: 30209078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardamonin retards progression of autosomal dominant polycystic kidney disease via inhibiting renal cyst growth and interstitial fibrosis.
    He J; Zhou H; Meng J; Zhang S; Li X; Wang S; Shao G; Jin W; Geng X; Zhu S; Yang B
    Pharmacol Res; 2020 May; 155():104751. PubMed ID: 32151678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
    Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
    Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of Hedgehog signaling suppresses proliferation and microcyst formation of human Autosomal Dominant Polycystic Kidney Disease cells.
    Silva LM; Jacobs DT; Allard BA; Fields TA; Sharma M; Wallace DP; Tran PV
    Sci Rep; 2018 Mar; 8(1):4985. PubMed ID: 29563577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterisation of transcription factor profiles in polycystic kidney disease (PKD): identification and validation of STAT3 and RUNX1 in the injury/repair response and PKD progression.
    Formica C; Malas T; Balog J; Verburg L; 't Hoen PAC; Peters DJM
    J Mol Med (Berl); 2019 Dec; 97(12):1643-1656. PubMed ID: 31773180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safe Nanocomposite-Mediated Efficient Delivery of MicroRNA Plasmids for Autosomal Dominant Polycystic Kidney Disease (ADPKD) Therapy.
    Tsai YC; Teng IL; Jiang ST; Lee YC; Chiou YY; Cheng FY
    Adv Healthc Mater; 2019 Mar; 8(5):e1801358. PubMed ID: 30672150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of TGF-β1 induces renal fibrosis and accelerates the decline in kidney function in polycystic kidney disease.
    Zhang Y; Dai Y; Raman A; Daniel E; Metcalf J; Reif G; Pierucci-Alves F; Wallace DP
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1135-F1148. PubMed ID: 33166182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.
    Belibi FA; Reif G; Wallace DP; Yamaguchi T; Olsen L; Li H; Helmkamp GM; Grantham JJ
    Kidney Int; 2004 Sep; 66(3):964-73. PubMed ID: 15327388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrin-Linked Kinase Signaling Promotes Cyst Growth and Fibrosis in Polycystic Kidney Disease.
    Raman A; Reif GA; Dai Y; Khanna A; Li X; Astleford L; Parnell SC; Calvet JP; Wallace DP
    J Am Soc Nephrol; 2017 Sep; 28(9):2708-2719. PubMed ID: 28522687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of follicle-stimulating hormone on biliary cyst growth in autosomal dominant polycystic kidney disease.
    Onori P; Mancinelli R; Franchitto A; Carpino G; Renzi A; Brozzetti S; Venter J; Francis H; Glaser S; Jefferson DM; Alpini G; Gaudio E
    Liver Int; 2013 Jul; 33(6):914-25. PubMed ID: 23617956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease.
    Cebotaru L; Liu Q; Yanda MK; Boinot C; Outeda P; Huso DL; Watnick T; Guggino WB; Cebotaru V
    Kidney Int; 2016 Jul; 90(1):90-9. PubMed ID: 27165822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quercetin inhibits renal cyst growth in vitro and via parenteral injection in a polycystic kidney disease mouse model.
    Zhu Y; Teng T; Wang H; Guo H; Du L; Yang B; Yin X; Sun Y
    Food Funct; 2018 Jan; 9(1):389-396. PubMed ID: 29215110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rosiglitazone inhibits insulin-like growth factor‑1-induced polycystic kidney disease cell growth and p70S6 kinase activation.
    Liu C; Zhang Y; Yuan L; Fu L; Mei C
    Mol Med Rep; 2013 Sep; 8(3):861-4. PubMed ID: 23864113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Notch3 as a novel therapeutic target for the treatment of ADPKD by regulating cell proliferation and renal cyst development.
    Su L; Chen T; Hu H; Xu Z; Luan X; Fu K; Ren Y; Sun D; Sun Y; Guo D
    Biochem Pharmacol; 2024 Jun; 224():116200. PubMed ID: 38604258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions between Macrophages and Cyst-Lining Epithelial Cells Promote Kidney Cyst Growth in
    Yang Y; Chen M; Zhou J; Lv J; Song S; Fu L; Chen J; Yang M; Mei C
    J Am Soc Nephrol; 2018 Sep; 29(9):2310-2325. PubMed ID: 30042193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD).
    Nikonova AS; Deneka AY; Kiseleva AA; Korobeynikov V; Gaponova A; Serebriiskii IG; Kopp MC; Hensley HH; Seeger-Nukpezah TN; Somlo S; Proia DA; Golemis EA
    FASEB J; 2018 May; 32(5):2735-2746. PubMed ID: 29401581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of polycystic kidney disease by non-coding RNAs.
    Ramalingam H; Yheskel M; Patel V
    Cell Signal; 2020 Jul; 71():109548. PubMed ID: 31982550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.